Skip to content

Assessment of a Diagnostic Medical Device for the INR (International Normalized Ratio) Measurement

Conformity Measurement Assessment of a Diagnostic Medical Device Used for the Measurement of the INR (International Normalized Ratio)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02779400
Acronym
HEMOPTICS2
Enrollment
220
Registered
2016-05-20
Start date
2016-05-23
Completion date
2018-06-01
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmias, Cardiac, Healthy, Heart Valves, Thromboembolism

Keywords

INR, coagulation, vitamin K antagonist

Brief summary

The purpose of this study is to assess the measurement conformity of an in vitro diagnostic device measuring the INR (International harmonized Ratio).

Detailed description

The investigators will assess the performance of an in vitro diagnostic device for assessing the INR. The evaluation will consist of make several INR measurements using the device and compare these measures to the reference value. The INR will be measured using the study device on capillary blood drops taken from the fingertip. In the same way a venous blood sampling will be carried out to measure a reference INR. A total of 20 healthy subjects and 180 patients treated with vitamin K agonist will be enrolled in the study.

Interventions

DEVICESelf testing INR device

the procedure involves a series of repeated measurements of INR with the studied device

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients treated with vitamin K agonist or healthy volunteers * For healthy volunteers : Body Mass index between 18 ans 29 kg/m² * No acute disease in the previous month

Exclusion criteria

* Pregnant woman

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of measurement of the INR with the study deviceJust after the blood taken at day 1The INR value of each measure with the study device will be compared to the reference INR measured by a central laboratory on a concomitant venous blood sample.

Secondary

MeasureTime frameDescription
Repeatability of measurement of the INR with the study deviceJust after the blood taken at day 1Comparison of 8 INR measurements performed with the device in a range of 15 minutes.
Reproductibility of measurement of the INR with the study deviceJust after the blood taken at day 1Comparison of 8 INR measurements performed with the device in a range of 15 minutes. The modified parameters between measurements will be the lot of consumables and the study device

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026